Bayer’s Q3 figures were positively impacted by Monsanto (contributing for a full quarter) and an enormous gain from the divestment of parts of the agro businesses. Stripping these effects out, the figures look a bit bare with just some top-line growth and some ailing profitability. The €3.2bn gain gave profitability a strong push far above our expectations but, on an adjusted basis, the group’s profitability came in below our expectations. Consensus top-line was not met, but
13 Nov 2018
Positive one-off and portfolio effect cover weak organic performance
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Positive one-off and portfolio effect cover weak organic performance
Bayer AG (BAYN:WBO) | 0 0 0.5% | Mkt Cap: 80,975m
- Published:
13 Nov 2018 -
Author:
Martin Schnee -
Pages:
4
Bayer’s Q3 figures were positively impacted by Monsanto (contributing for a full quarter) and an enormous gain from the divestment of parts of the agro businesses. Stripping these effects out, the figures look a bit bare with just some top-line growth and some ailing profitability. The €3.2bn gain gave profitability a strong push far above our expectations but, on an adjusted basis, the group’s profitability came in below our expectations. Consensus top-line was not met, but